Last reviewed · How we verify

NCT03826251

Small Bowel Obstruction and Surgery

Completed Last updated 1 February 2019
What this trial tests

trial testing Nasogastric tube removal in Acute Small Intestine Obstruction in 190 participants. Completed in 1 June 2018.

Timeline
1 January 2014
Primary endpoint
31 December 2017
1 June 2018

Quick facts

Lead sponsorUniversity Hospital, Angers
StatusCompleted
Study typeOBSERVATIONAL
Enrollment190
Start date1 January 2014
Primary completion31 December 2017
Estimated completion1 June 2018

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Angers

Who can join

Adults 18 to 99, any sex, with Acute Small Intestine Obstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative management after small bowel obstruction (SBO) surgery is not consensual and better knowledge of risk factors for postoperative morbidity could help to add evidence of the feasibility of enhanced recovery programs (ERPs). In elective surgery, ERPs have shown a significant benefit for the patient but this is not performed routinely in emergency surgery due to the difficulty to avoid postoperative nasogastric tube. The aim was to identify risk factors for postoperative morbidity and for nasogastric tube (NGT) replacement after SBO surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Angers trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03826251.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing